Skip to main content

Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate) Shopper Approved

Prescription Prescription Required FormationFormulation: Inhalation Powder

Trelegy Ellipta

(Brand Option)

Select the prescribed dosage

Select the quantity to see the price.

  *  
Prescription Prescription Required FormationFormulation: Inhalation Powder

Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate

(Generic Alternative)

Select the prescribed dosage

Select the quantity to see the price.

  *  
delivery

* This price includes a dispensing fee, medical review fee, and packing fee.

delivery

Shipped and delivered directly to your doorstep

Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate) is a prescription inhaler used for the long-term treatment of chronic obstructive pulmonary disease (COPD) in adults. It contains three active ingredients: fluticasone furoate, umeclidinium, and vilanterol.

COPD is a long-term lung disease that causes inflammation, narrowing, and damage within the airways and lungs. It includes conditions such as chronic bronchitis and emphysema. People with COPD may experience shortness of breath, ongoing coughing, wheezing, chest tightness, increased mucus production, and difficulty completing everyday activities.

Trelegy Ellipta is used as a maintenance treatment, which means it is taken regularly to help control COPD over time. It can help improve airflow, reduce ongoing respiratory symptoms, improve lung function, and lower the risk of COPD flare-ups, also known as exacerbations. A COPD flare-up is a sudden worsening of symptoms that may require additional medication, urgent medical care, or hospitalization.

Trelegy Ellipta combines three types of inhaled medication that work together to improve breathing.

Fluticasone Furoate

Fluticasone furoate is an inhaled corticosteroid, also called an ICS. COPD can cause ongoing inflammation and swelling inside the airways, making it more difficult for air to move through the lungs.

Fluticasone furoate helps reduce this inflammation and swelling. By calming the inflammatory response in the airways, it can help reduce irritation and support better long-term symptom control.

Vilanterol

Vilanterol is a long-acting beta2-adrenergic agonist, also called a LABA. It works by relaxing the muscles that surround the airways.

When these muscles relax, the airways become wider and allow air to move more easily in and out of the lungs. Because vilanterol is long-acting, its bronchodilator effect helps keep the airways open throughout the day.

Umeclidinium

Umeclidinium is a long-acting muscarinic antagonist, also called a LAMA. Certain nerve signals can cause the muscles surrounding the airways to tighten and narrow.

Umeclidinium blocks these signals, helping prevent the airway muscles from tightening. This allows the airways to remain more open and may reduce symptoms such as wheezing, chest tightness, and shortness of breath.

How the Three Ingredients Work Together

Each ingredient in Trelegy Ellipta addresses a different part of COPD. Fluticasone furoate reduces airway inflammation, while vilanterol and umeclidinium relax the airway muscles through different mechanisms.

Together, these medications help reduce inflammation, prevent airway narrowing, improve airflow, and make breathing easier. Using three medications in one inhaler may also make the treatment routine more convenient for patients who need all three types of therapy.

With regular use, Trelegy Ellipta may help patients experience fewer symptoms, participate more comfortably in everyday activities, and reduce the frequency of COPD flare-ups. However, individual results may vary, and the medication must be used consistently as prescribed.

Trelegy Ellipta controls COPD symptoms but does not cure COPD or reverse existing lung damage. Patients should continue following their complete COPD-management plan, which may include avoiding smoking, participating in pulmonary rehabilitation, staying physically active as recommended, and receiving appropriate vaccinations.

Maintenance Treatment, Not Emergency Relief

Trelegy Ellipta is not a rescue inhaler. It does not work quickly enough to relieve sudden or severe breathing problems, such as an acute COPD attack.

Patients should use a fast-acting rescue inhaler for sudden symptoms, according to their healthcare provider’s instructions. Medical attention may be required if the rescue inhaler does not relieve symptoms or if breathing suddenly becomes much worse.

Trelegy Ellipta should be used every day as prescribed, even when COPD symptoms appear to be well controlled. Regular use helps maintain its effects throughout the day and provides ongoing protection against airway inflammation and narrowing.

Trelegy Ellipta is a dry-powder inhaler used once daily, as directed by a healthcare provider. The medication is inhaled through the mouth and should be taken at approximately the same time each day.

Do not open the inhaler cover until you are ready to take your dose. Each time you open the cover, one dose is prepared. If you open and close the cover without inhaling the medication, that dose may be lost and cannot be recovered.

You may or may not taste or feel the medication when you inhale it. This does not necessarily mean that the inhaler did not work. Do not breathe out into the inhaler because moisture from your breath may affect the medication inside the device.

Step-by-Step Instructions

Open the packaging

Peel back the lid of the inhaler tray and remove the inhaler. Dispose of the moisture-absorbing packet, also called the desiccant. Do not open, eat, or inhale the contents of the packet.

Check the dose counter on the inhaler. A new inhaler should display “30.” A sample inhaler may display “14.”

Prepare the dose

When you are ready to take your medication, slide the inhaler cover downward until you hear a click and the mouthpiece is fully visible.

The dose counter will decrease by one, indicating that a dose has been prepared. Do not close the cover until after you have inhaled the medication.

Breathe out

Hold the inhaler away from your mouth and breathe out slowly and completely.

Do not breathe out into the mouthpiece.

Inhale the medication

Place the mouthpiece between your lips and close your lips firmly around it. Do not cover the air vent with your fingers.

Take one long, steady, and deep breath through your mouth. Do not breathe in through your nose while taking the dose.

Hold your breath

Remove the inhaler from your mouth and hold your breath for approximately three to four seconds, or for as long as is comfortable.

Then breathe out slowly and gently.

Close the inhaler

Slide the cover upward until it completely covers the mouthpiece.

Rinse your mouth

After using Trelegy Ellipta, rinse your mouth with water and spit the water out. Do not swallow it.

Rinsing your mouth helps reduce the risk of oral thrush, a fungal infection that may cause white patches, soreness, or irritation inside the mouth.

Important Reminders

Use Trelegy Ellipta once daily and do not take more than one dose within 24 hours unless specifically instructed by your healthcare provider.

Trelegy Ellipta is a maintenance inhaler. It should not be used to treat sudden breathing problems. Use your prescribed rescue inhaler for sudden symptoms.

Keep the inhaler dry and do not wash it with water. The mouthpiece may be cleaned with a dry tissue when needed.

Continue using Trelegy Ellipta every day, even when you feel well. Do not stop treatment without speaking with your healthcare provider.

Common Side Effects of Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate):

  • Headache
  • Hoarseness/throat irritation
  • Change in taste
  • Cough
  • Back pain

Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate) Allergic Reactions:

  • Trouble breathing
  • Itching
  • Rashes
  • Hives
  • Swelling of the mouth or the entire face
  • Severe dizziness
  • Trouble sleeping

Serious Side Effects of Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate):

  • Easy bruising
  • Bleeding
  • Tremors
  • White patches in the mouth
  • Increased thirst
  • Painful urination
  • Muscle weakness
  • Bone pain

Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate) is available in the following forms and strength:

Trelegy Ellipta: Inhalation Powder

  • 100/62.5/25 mcg
  • 200/62.5/25 mcg

Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate: Inhalation Powder

  • 100/62.5/25 mcg

Before starting Trelegy Ellipta, tell your doctor or pharmacist about any allergies you have. This is especially important if you are allergic to fluticasone furoate, umeclidinium, vilanterol, corticosteroids, anticholinergic medications, or milk proteins.

Trelegy Ellipta contains lactose, which may contain small amounts of milk protein. People with a severe milk protein allergy should not use this medication because it may cause a serious allergic reaction. A milk protein allergy is different from lactose intolerance. People with lactose intolerance usually have difficulty digesting lactose, while a milk protein allergy involves an immune-system reaction.

Seek immediate medical attention if you experience signs of a serious allergic reaction, including difficulty breathing, wheezing, hives, severe rash, dizziness, or swelling of the face, lips, tongue, mouth, or throat.

Heart and Blood Vessel Conditions

Trelegy Ellipta should be used cautiously in people with certain heart or blood vessel conditions. Tell your healthcare provider if you have:

  • Coronary artery disease or reduced blood flow to the heart
  • High blood pressure
  • An irregular heartbeat
  • A fast heartbeat
  • Heart failure
  • Other cardiovascular conditions

Vilanterol, one of the active ingredients in Trelegy Ellipta, is a long-acting beta2-adrenergic agonist. Medications in this class may sometimes increase heart rate, raise blood pressure, or cause changes in heart rhythm.

Contact your healthcare provider if you develop chest pain, a fast or pounding heartbeat, worsening shortness of breath, dizziness, or fainting while using Trelegy Ellipta.

Corticosteroid Sensitivity

Trelegy Ellipta contains fluticasone furoate, an inhaled corticosteroid that helps reduce inflammation in the airways.

Tell your healthcare provider if you have ever experienced an allergic reaction or unusual sensitivity to a corticosteroid medication. Although inhaled corticosteroids mainly act inside the lungs, they may still cause local or body-wide side effects, particularly when used at higher doses or for long periods.

Avoid Similar Medications

Do not use Trelegy Ellipta with another medication that contains a long-acting beta2-adrenergic agonist, also known as a LABA, unless your healthcare provider specifically tells you to do so. Using more than one LABA medication may increase the risk of serious side effects, including a rapid heartbeat, irregular heart rhythm, tremors, headache, or changes in blood pressure.

You should also avoid using Trelegy Ellipta with another anticholinergic medication unless directed by your healthcare provider. Umeclidinium, one of the ingredients in Trelegy Ellipta, is an anticholinergic. Combining it with similar medications may increase side effects such as dry mouth, constipation, difficulty urinating, blurred vision, or worsening glaucoma symptoms.

Always check with your doctor or pharmacist before starting a new inhaler, cold medication, allergy medicine, or other treatment.

Medical Conditions to Discuss

Before using Trelegy Ellipta, tell your healthcare provider about all your current and previous medical conditions. This includes:

  • Heart disease or high blood pressure
  • Irregular heart rhythms
  • Glaucoma or increased pressure inside the eyes
  • An enlarged prostate or difficulty urinating
  • Seizures
  • Thyroid disorders
  • Diabetes
  • Liver problems
  • Osteoporosis or a history of bone fractures
  • Tuberculosis
  • A weakened immune system
  • Current or recurring infections
  • Eye conditions such as cataracts

This information helps your healthcare provider decide whether Trelegy Ellipta is appropriate for you and whether additional monitoring is needed.

Medication Interactions

Tell your healthcare provider about all the products you take, including prescription medications, non-prescription medicines, vitamins, supplements, herbal products, and other inhalers.

Some medications may interact with Trelegy Ellipta or increase the risk of side effects. These may include certain heart medicines, blood pressure medications, antidepressants, antifungal medications, antiviral treatments, diuretics, and medicines that affect the immune system.

Keep an updated medication list and share it with every healthcare provider involved in your care. Do not begin, stop, or change the dose of any medication without first speaking with your doctor or pharmacist.

Pregnancy and Breastfeeding

Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. Your provider will consider the potential benefits and possible risks before recommending Trelegy Ellipta.

Important Safety Reminder

Trelegy Ellipta is intended for regular maintenance treatment. It should not be used to relieve sudden breathing problems. Keep your prescribed rescue inhaler available and seek urgent medical attention if your breathing suddenly becomes worse or your rescue medication does not provide relief.

Does Trelegy Ellipta Cause Breathing Problems?

Trelegy Ellipta is used to improve breathing and control ongoing symptoms in people with asthma or chronic obstructive pulmonary disease (COPD). However, in rare cases, an inhaled medication may cause sudden tightening of the airways immediately after use. Seek medical attention if your breathing suddenly becomes worse after using Trelegy Ellipta, especially if you develop severe wheezing, chest tightness, or shortness of breath.

What Should I Do if My Breathing Is Getting Worse Quickly? 

Trelegy Ellipta is not intended to treat a sudden breathing emergency. If your breathing problems are worsening quickly, use your prescribed rescue inhaler as directed and seek immediate medical attention. You should also contact your healthcare provider if your rescue inhaler is not working as well as usual or if you need to use it more frequently.

How Often Should I Use Trelegy Ellipta?

The usual recommended dose of Trelegy Ellipta is one inhalation once daily. Try to use it at approximately the same time each day to help maintain consistent symptom control. Do not use more than one dose within 24 hours unless your healthcare provider specifically tells you to do so.

Can Trelegy Ellipta Treat Sudden COPD or Asthma Symptoms?

No. Trelegy Ellipta is a maintenance medication used every day to control chronic asthma or COPD symptoms. It does not work quickly enough to relieve a sudden asthma attack, COPD flare-up, or severe episode of shortness of breath. A fast-acting rescue inhaler should be used for sudden breathing symptoms, according to your healthcare provider’s instructions.

How Long Does Trelegy Ellipta Take to Work?

Trelegy Ellipta begins working after it is inhaled, and some people may notice an improvement in breathing relatively quickly. However, it may take several days or weeks of regular use to experience the medication’s full benefits. Continue using Trelegy Ellipta every day as prescribed, even if you do not notice immediate improvement. Contact your healthcare provider if your symptoms do not improve or become worse.

REVIEWS

Additional Information Book
Generic name:

Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate, Fluticasone furoate/Umeclidinium Bromide/Vilanterol Trifenatate

Formulation:

Inhalation Powder

Strength(s):

100/62.5/25mcg, 200/62.5/25mcg

Quantities Available:

30 doses, 30doses, 60 doses, 90 doses, 120 doses

Why customers love Online Pharmacies Canada

Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.

Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.

How to Order

How much Trelegy Ellipta can I order at once from a Canadian pharmacy?

When ordering Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.

Here’s what you need to know:

Dosage and Quantity: Trelegy Ellipta comes in two strengths: 100/62.5/25 mcg and 200/62.5/25 mcg and is commonly prescribed as one inhalation once daily. For a 90-day supply, this means you would order 90 inhalations (90 days x 1 inhalation per day).

Do you sell fluticasone furoate/umeclidinium/vilanterol?

No, we do not sell fluticasone furoate/umeclidinium/vilanterol directly on our website. However, you can still benefit from competitive prices on Trelegy Ellipta, which contains fluticasone furoate/umeclidinium/vilanterol as its active ingredients. To purchase Trelegy Ellipta from us, you will need a valid prescription from your healthcare provider. This prescription is necessary for us to dispense the medication safely and in compliance with regulations. You can conveniently submit your prescription by mailing it, faxing it, or uploading it through your online account on our website.

Do you offer shipping of Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol) to the United States?

Yes, we ship Trelegy Ellipta (fluticasone furoate / umeclidinium / vilanterol) to both the United States and Puerto Rico.

Discover Our Users' Stories!

Watch how Online Pharmacies Canada is helping customers save money on their medications.

Online Pharmacies Canada Customer Testimonial #4
Online Pharmacies Canada Customer Testimonial #1
Online Pharmacies Canada - Customer Testimonial #2

Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Trelegy Ellipta (Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate).